Octave Specialty (OSG) Other Accumulated Expenses (2016 - 2026)

Octave Specialty's Other Accumulated Expenses history runs 10 years deep, the most recent figure standing at $487.3 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 30.6% year-over-year to $487.3 million; the TTM figure through Mar 2026 stood at $487.3 million (up 30.6% YoY), while the FY2025 annual figure was $460.0 million, up 31.78% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $487.3 million, up from $460.0 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $938.0 million in Q3 2024, with the low at $89.9 million in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $437.5 million (2025), against an average of $496.1 million.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses sank 94.15% in 2022, then surged 119.21% in 2023.
• Octave Specialty's Other Accumulated Expenses stood at $89.9 million in 2022, then jumped by 119.21% to $197.1 million in 2023, then jumped by 77.11% to $349.1 million in 2024, then surged by 31.78% to $460.0 million in 2025, then increased by 5.93% to $487.3 million in 2026.
• Business Quant data shows OSG's Other Accumulated Expenses at $487.3 million in Q1 2026, $460.0 million in Q4 2025, and $437.5 million in Q3 2025.